2012
DOI: 10.1007/s00740-012-0437-9
|View full text |Cite
|
Sign up to set email alerts
|

Multimodale Therapie bei NSCLC

Abstract: Behandlung und Prognose des nicht kleinzelligen Bronchuskarzinoms (NSCLC) sind abhängig vom Tumorstadium des Patienten. Das mediastinale Lymphknotenstaging ist entscheidend, um die optimale Th erapiestrategie festzulegen. Ein ipsilateraler mediastinaler Lymphknotenbefall (N2) bedeutet zumindest ein Stadium IIIA, in dem ein multimodales Th erapiekonzept mit Induktionschemotherapie bzw. -chemoradiotherapie mit nachfolgender Operation bei entsprechendem Downstaging das etablierte Standardverfahren ist. Die Identi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
3
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(3 citation statements)
references
References 41 publications
0
3
0
Order By: Relevance
“…[ 199 ] The technology of holographic 2PP was patented and commercialized for the generation of tissue models by Prellis biologics, which was founded in 2016. [ 200–202 ]…”
Section: Trends Limitations and Outlook Of The Mpl Technologymentioning
confidence: 99%
See 2 more Smart Citations
“…[ 199 ] The technology of holographic 2PP was patented and commercialized for the generation of tissue models by Prellis biologics, which was founded in 2016. [ 200–202 ]…”
Section: Trends Limitations and Outlook Of The Mpl Technologymentioning
confidence: 99%
“…[199] The technology of holographic 2PP was patented and commercialized for the generation of tissue models by Prellis biologics, which was founded in 2016. [200][201][202] While multifocus 2PP can be an interesting approach to create periodic structures, the movement of these multiple focal spots remains dependent on the mechanical equipment of the system. [198] In this respect, a significant increase in performance was achieved via the incorporation of galvo mirrors in multiphoton lithography, resulting in writing speeds up to 5 m s −1 as first reported by researchers of TU Wien (Austria) in 2012.…”
Section: Trends Limitations and Outlook Of The Mpl Technologymentioning
confidence: 99%
See 1 more Smart Citation